Nasri Jordan, Beraud Florian, Seguier Denis, Delporte Gauthier, Behal Hélène, Olivier Jonathan, Villers Arnauld, Marcelli François, Biardeau Xavier
Department of Urology, CHU Lille, Claude Huriez Hospital, Univ. Lille, 59000, Lille, France.
ULR 2694-METRICS: Évaluation Des Technologies de Santé Et Des Pratiques Médicales, CHU Lille, Univ. Lille, 59000, Lille, France.
World J Urol. 2021 Sep;39(9):3541-3547. doi: 10.1007/s00345-021-03673-x. Epub 2021 Mar 27.
To assess feasibility, safety and risk factors for failure associated with out-patient surgery for artificial urinary sphincter (AUS) implantation/revision in non-neurogenic men.
In the present retrospective monocentric study conducted between May 2016 and March 2020, 81 patients undergoing AUS implantation or revision during an out-patient surgery were included. The primary outcome was the success rate of out-patient surgery. Success was assessed using two distinct definitions, a narrow definition, where success was defined as a one-day hospitalization and the absence of any unscheduled consultation or re-hospitalization within the 3 days following surgery, a broad definition, where success was defined as a one-day hospitalization and the absence of any unscheduled re-hospitalization within the 3 days following surgery. In parallel, risk factors for failure of out-patient surgery, as well as efficacy and safety were assessed.
Eighty-one patients were enrolled, with a mean age of 71.2 years ± 5.9. Out-patient surgery was successfully completed in 58 men (71.6% [95% CI 60.5-81.1]) and in 76 men (93.8% [95% CI 86.2-97.9]) according to the narrow and the broad definition, respectively. After multivariate analysis, anticoagulant therapy (OR 25.97 [95% CI 4.44-152.04]) and low socio-professional status (OR 22.1 [95% CI 3.701-131.95]) were statistically associated with failure of out-patient surgery. The continence rate after a 90-day follow-up was 79%.
AUS implantation/revision in non-neurogenic men could be safely proposed in out-patient surgery. Special attention may however be paid to patients undergoing anticoagulant therapy or belonging to a low socio-professional category.
DEC20-173 (French National Commission for Data Protection and Liberties).
评估非神经源性男性患者门诊行人工尿道括约肌(AUS)植入/翻修手术的可行性、安全性及失败相关风险因素。
在2016年5月至2020年3月进行的这项回顾性单中心研究中,纳入了81例在门诊手术中接受AUS植入或翻修的患者。主要结局是门诊手术成功率。成功率采用两种不同定义进行评估,狭义定义为术后住院1天且术后3天内无任何非计划内会诊或再次住院;广义定义为术后住院1天且术后3天内无任何非计划内再次住院。同时,评估门诊手术失败的风险因素以及疗效和安全性。
共纳入81例患者,平均年龄71.2岁±5.9岁。根据狭义和广义定义,门诊手术分别成功完成58例(71.6% [95%CI 60.5 - 81.1])和76例(93.8% [95%CI 86.2 - 97.9])。多因素分析后,抗凝治疗(OR 25.97 [95%CI 4.44 - 152.04])和社会职业地位低(OR 22.1 [95%CI 3.701 - 131.95])与门诊手术失败在统计学上相关。90天随访后的控尿率为79%。
非神经源性男性患者门诊行AUS植入/翻修手术是安全可行的。然而,对于接受抗凝治疗或社会职业地位较低的患者可能需要特别关注。
DEC20 - 173(法国国家数据保护与自由委员会)